Massachusetts General Hospital

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Massachusetts General Hospital sits in the top decile of US sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count).

2,032 total trials 336 currently recruiting 1284 completed early-phase tilt top decile by trial count

Massachusetts General Hospital: 2,032 sponsored US clinical trials, 336 recruiting.

Massachusetts General Hospital sponsors 2,032 registered US clinical trials on ClinicalTrials.gov, 336 of them currently recruiting, and 1,284 completed. 240 of these trials are in Phase 3-4 (later-stage) and 515 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 29 trials.

Top-decile sponsor footprint

Massachusetts General Hospital ranks in the top decile of sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

2,032 total, page 7 of 41

RECRUITING NA

Developing Viability Index for Machine Perfused Livers

NCT03694691

RECRUITING NA

Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy

NCT03286335

RECRUITING NA

Imaging Histone Deacetylase in the Heart

NCT03549559

RECRUITING NA

Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study

NCT04496947

RECRUITING Phase 1

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

NCT03535545

RECRUITING Phase 2

Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

NCT03482102

RECRUITING Phase 2

BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study

NCT02481245

RECRUITING NA

Pilot Study for OCT Guided In Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's Esophagus

NCT03830801

RECRUITING

Biomarker Profiling in Individuals at Risk for Prion Disease

NCT05124392

RECRUITING NA

Turmeric for Patients With Basal Joint Arthritis

NCT03017118

RECRUITING Early Phase 1

Diffusion MRI in Heart Failure

NCT02973633

RECRUITING

Stroke Motor Rehabilitation and Recovery Study

NCT03485040

RECRUITING Phase 2

Palbociclib and Pembrolizumab In Central Nervous System Metastases

NCT02896335

RECRUITING

Partners Calciphylaxis Biobank

NCT03032835

RECRUITING NA

Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

NCT02792270

RECRUITING NA

Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System

NCT02947971

RECRUITING

Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure

NCT03480633

RECRUITING Phase 1

Positron Emission Tomography (PET) Imaging of Thrombosis

NCT03830320

RECRUITING

The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes

NCT07022951

RECRUITING

ALS/MND Natural History Study Data Repository

NCT05966038

RECRUITING NA

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

NCT02290834

RECRUITING

Biomarker Development for Muscular Dystrophies

NCT05019625

RECRUITING Phase 1

Bronchial NIR Image-guided Resection

NCT03097575

RECRUITING Phase 4

Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment

NCT02283996

RECRUITING NA

Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

NCT04296604

RECRUITING NA

Phase II Study of Proton Radiation Therapy for Neuroblastoma

NCT02112617

RECRUITING

Celiac Disease Genomic Environmental Microbiome and Metabolomic Study

NCT02061306

RECRUITING

A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

NCT02118922

RECRUITING Phase 1

Proton or Photon RT for Retroperitoneal Sarcomas

NCT01659203

RECRUITING

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

NCT01696721

RECRUITING NA

A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

NCT01873131

RECRUITING

Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy

NCT01961713

RECRUITING

Prospective Screening for Breast Cancer-related Lymphedema

NCT01521741

RECRUITING

National Pregnancy Registry for Psychiatric Medications

NCT01246765

RECRUITING

DNA Analysis of Blood and Tissue from Patients with Lung Cancer

NCT00471978

RECRUITING

Molecular and Genetic Analysis of Lung Cancer

NCT03029325

ACTIVE NOT RECRUITING NA

Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair

NCT07498166

ACTIVE NOT RECRUITING Phase 2

Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)

NCT07047209

ACTIVE NOT RECRUITING NA

Resilient Families Open Pilot: Dyadic Resiliency Intervention

NCT06239571

ACTIVE NOT RECRUITING NA

Open Pilot Trial of a Mind-Body Intervention for Patients With Chronic Hip Pain

NCT06820242

ACTIVE NOT RECRUITING Phase 2

Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression

NCT05774665

ACTIVE NOT RECRUITING Phase 1

Integrating Ketamine Effects on Neuronal Molecular Signatures and the Brain Functional and Structural Connectome

NCT06698848

ACTIVE NOT RECRUITING Phase 2

Vedolizumab for the Treatment of Collagenous Gastritis

NCT06317220

ACTIVE NOT RECRUITING Phase 4

Sequential Multiple Assignment Randomized Trial for Bipolar Depression

NCT06433635

ACTIVE NOT RECRUITING NA

Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease

NCT06458127

ACTIVE NOT RECRUITING NA

CHW Intervention to Improve Nutrition Security of Patients With Hypertension

NCT06358417

ACTIVE NOT RECRUITING NA

Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease

NCT05737602

ACTIVE NOT RECRUITING NA

REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults

NCT06000813

ACTIVE NOT RECRUITING NA

Preventing Disordered Eating and Body Dissatisfaction Among High-risk Pregnant Individuals

NCT06659354

ACTIVE NOT RECRUITING

Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia Longitudinal Assessment Study

NCT07018401

← Previous Page 7 of 41 Next →

Phase Distribution

PhaseTrial count
Phase 1 226
Phase 2 289
Phase 3 58
Phase 4 182

What is open in the Massachusetts General Hospital pipeline

336 recruiting of 2,032 indexed (17% open); 1,284 completed (63%).

Phase mix: 240 late (III/IV) vs 515 early (I/II) (early-phase heavy).

Top condition: Depression (29 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.